Literature DB >> 1718228

Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

R M Hoet1, A M Boerbooms, M Arends, D J Ruiter, W J van Venrooij.   

Abstract

The antiperinuclear factor, an autoantibody specific for rheumatoid arthritis, was found in 51/63 (81%) patients with rheumatoid arthritis by indirect immunofluorescence on human buccal mucosa cells. The sensitivity of the antiperinuclear factor test was increased by pretreating the buccal mucosa cells with 0.5% Triton-X100. The specificity of the test for rheumatoid arthritis as compared with control serum samples was maintained. The localisation of the perinuclear factor in the keratohyalin granules of the buccal mucosa cells was verified by immunoelectron microscopy. The perinuclear factor was found to be an insoluble protein whose antigenicity was sensitive to various fixation procedures. In serum samples from patients with rheumatoid arthritis there was a positive correlation between the presence of antiperinuclear factor and the presence of the so called antikeratin antibodies as detected by immunofluorescence on unfixed rat oesophagus cryostat sections. No relation was found between the presence of the perinuclear factor and either the rheumatoid factor, Epstein-Barr virus components, or any cytokeratin. By double immunofluorescence an exact colocalisation of the perinuclear factor and profilaggrin was found. Although the precise biochemical identity of the perinuclear factor remains unclear, our results suggest that it is a protein only present in the fully differentiated squamous epithelial cell layer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718228      PMCID: PMC1004503          DOI: 10.1136/ard.50.9.611

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  47 in total

1.  [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].

Authors:  P Youinou; P Le Goff; P Miossec; M P Moineau; C Ferec
Journal:  Z Rheumatol       Date:  1983 Jan-Feb       Impact factor: 1.372

Review 2.  Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins.

Authors:  E Lazarides
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

3.  Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.

Authors:  P B Billings; R W Allen; F C Jensen; S O Hoch
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

4.  Anti-perinuclear and rheumatoid factor in different forms of autoimmune thyroid disease.

Authors:  W A Scherbaum; P Y Youinou; P Le Goff; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

5.  Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus.

Authors:  A Alcover; J Molano; J Renart; A Gil-Aguado; A Nieto; J Avila
Journal:  Arthritis Rheum       Date:  1984-08

6.  Evidence for relationships between antiperinuclear and IgG rheumatoid factor.

Authors:  P Youinou; P Le Goff; R Casburn-Budd; C Ferec; Y Pennec
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

7.  Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.

Authors:  F Ramaekers; A Huysmans; O Moesker; A Kant; P Jap; C Herman; P Vooijs
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

8.  Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease.

Authors:  R K Mallya; B J Young; M B Pepys; T J Hamblin; B E Mace; E B Hamilton
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

9.  Antibodies to cytoplasmic intermediate filaments in rheumatic diseases.

Authors:  P Kurki; T Helve; I Virtanen
Journal:  J Rheumatol       Date:  1983-08       Impact factor: 4.666

10.  Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies.

Authors:  J Woodcock-Mitchell; R Eichner; W G Nelson; T T Sun
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more
  20 in total

1.  Antiperinuclear factor in chronic juvenile arthritis.

Authors:  R von Essen; H Ylijoki; A Savolainen; J Haapasaari; U M Oksala
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies.

Authors:  Frederique Dubois-Galopin; Celine Beauvillain; Damien Dubois; Anne Pillet; Gilles Renier; Pascale Jeannin; Charles Masson; Alain Chevailler
Journal:  Ann Rheum Dis       Date:  2007-08       Impact factor: 19.103

Review 3.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

4.  The rheumatoid arthritis-associated autoantibodies to filaggrin label the fibrous matrix of the cornified cells but not the profilaggrin-containing keratohyalin granules in human epidermis.

Authors:  M Simon; C Vincent; M Haftek; E Girbal; M Sebbag; V Gomès-Daudrix; G Serre
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

5.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

Authors:  M Simon; E Girbal; M Sebbag; V Gomès-Daudrix; C Vincent; G Salama; G Serre
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.

Authors:  Kristine A Kuhn; Liudmila Kulik; Beren Tomooka; Kristin J Braschler; William P Arend; William H Robinson; V Michael Holers
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

8.  Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.

Authors:  N Després; G Talbot; B Plouffe; G Boire; H A Ménard
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.

Authors:  C Gabay; A M Prieur; O Meyer
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

10.  Antiperinuclear factor: a useful test for the diagnosis of rheumatoid arthritis.

Authors:  S Muñoz-Fernández; R Alvarez-Doforno; M Cuesta; A Balsa; G Fontán; J Gijón-Baños
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.